Literature DB >> 12443804

Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques.

Jonas Johansson1, Ulf Isacsson, Henrik Lindman, Anders Montelius, Bengt Glimelius.   

Abstract

PURPOSE: To determine how much proton and intensity modulated photon radiotherapy (IMRT) can improve treatment results of node-positive left-sided breast cancer compared to conventional radiation qualities (X-rays and electrons) after breast-conserving surgery in terms of lower complication risks for cardiac mortality and radiation pneumonitis. METHODS AND MATERIAL: For each of 11 patient studies, one proton plan, one IMRT, and two conventional (tangential and patched) plans were calculated using a three-dimensional treatment-planning system, Helax-TMS(). The evaluation of the different treatment plans was made by applying the normal tissue complication probability model (NTCP) proposed by Källman (also denoted the relative seriality model) on the dose distributions in terms of dose-volume histograms. The organs at risk are the spinal cord, the left lung, the heart, and the non-critical normal tissues (including the right breast).
RESULTS: The comparison demonstrated that the proton treatment plans provide significantly lower NTCP values for the heart and lung when compared to conventional radiation qualities including IMRT for all 11 patients. At a prescribed dose of 50 Gy in the PTV, the calculated mean NTCP value for the patients decreased, on the average, from 14.7 to 0.6% for the lung (radiation pneumonitis) for the proton plans compared with the best plan using conventional radiation qualities. The corresponding figures for the heart (cardiac mortality) were from 2.1 to 0.5%. The figures for cardiac mortality for IMRT, tangential technique and the patched technique were 2.2, 6.7, and 2.1%, respectively.
CONCLUSIONS: Protons appear to have major advantages in terms of lower complication risks when compared with treatments using conventional radiation qualities for treating node-positive left-sided breast cancer after breast-conserving surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443804     DOI: 10.1016/s0167-8140(02)00266-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

Review 1.  Promise and pitfalls of heavy-particle therapy.

Authors:  Timur Mitin; Anthony L Zietman
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

Review 2.  Expanding the therapeutic index of radiation therapy by normal tissue protection.

Authors:  Pierre Montay-Gruel; Lydia Meziani; Chakradhar Yakkala; Marie-Catherine Vozenin
Journal:  Br J Radiol       Date:  2018-07-02       Impact factor: 3.039

3.  The evolution of proton beam therapy: Current and future status.

Authors:  Xiufang Tian; Kun Liu; Yong Hou; Jian Cheng; Jiandong Zhang
Journal:  Mol Clin Oncol       Date:  2017-11-14

4.  A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy.

Authors:  Margaret Hernandez; Rui Zhang; Mary Sanders; Wayne Newhauser
Journal:  J Proton Ther       Date:  2015

5.  Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.

Authors:  Rui Zhang; David Heins; Mary Sanders; Beibei Guo; Kenneth Hogstrom
Journal:  Med Phys       Date:  2018-05-27       Impact factor: 4.071

Review 6.  Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview.

Authors:  Damien C Weber; Carmen Ares; Antony J Lomax; John M Kurtz
Journal:  Radiat Oncol       Date:  2006-07-20       Impact factor: 3.481

Review 7.  Benefits, risks, and safety of external beam radiation therapy for breast cancer.

Authors:  Lindsay C Brown; Robert W Mutter; Michele Y Halyard
Journal:  Int J Womens Health       Date:  2015-04-24

Review 8.  Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast-conserving surgery and radiation therapy: a review.

Authors:  Robert E Beck; Leonard Kim; Ning J Yue; Bruce G Haffty; Atif J Khan; Sharad Goyal
Journal:  Front Oncol       Date:  2014-11-14       Impact factor: 6.244

Review 9.  The clinical case for proton beam therapy.

Authors:  Robert L Foote; Scott L Stafford; Ivy A Petersen; Jose S Pulido; Michelle J Clarke; Steven E Schild; Yolanda I Garces; Kenneth R Olivier; Robert C Miller; Michael G Haddock; Elizabeth Yan; Nadia N Laack; Carola A S Arndt; Steven J Buskirk; Vickie L Miller; Christopher R Brent; Jon J Kruse; Gary A Ezzell; Michael G Herman; Leonard L Gunderson; Charles Erlichman; Robert B Diasio
Journal:  Radiat Oncol       Date:  2012-10-22       Impact factor: 3.481

10.  Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.

Authors:  Giorgio Cartechini; Francesco Fracchiolla; Loris Menegotti; Emanuele Scifoni; Chiara La Tessa; Marco Schwarz; Paolo Farace; Francesco Tommasino
Journal:  Radiat Oncol       Date:  2020-10-02       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.